Calcitriol Injection

— THERAPEUTIC CATEGORIES —
  • Secondary hyperparathyroidism or hypocalcemia

Calcitriol Injection Generic Name & Formulations

General Description

Calcitriol 1mcg/mL; soln for IV inj.

Pharmacological Class

Vit. D analog.

How Supplied

Contact supplier.

Calcitriol Injection Indications

Indications

Hypocalcemia in patients on chronic renal dialysis. Secondary hyperparathyroidism.

Calcitriol Injection Dosage and Administration

Adult

≥13yrs: Initially 1–2mcg (0.02mcg/kg) 3 times weekly (approx. every other day); usual range: 0.5–4mcg 3 times weekly. May increase by 0.5–1mcg at 2–4 week intervals. Adjust dose based on PTH levels: see full labeling.

Children

<13yrs: not recommended.

Calcitriol Injection Contraindications

Contraindications

Hypercalcemia. Vit. D toxicity.

Calcitriol Injection Boxed Warnings

Not Applicable

Calcitriol Injection Warnings/Precautions

Warnings/Precautions

Avoid concurrent Vit. D therapy. Maintain adequate calcium intake. Keep serum calcium times phosphate (Ca x P) product below 70. Monitor serum calcium and phosphorus twice weekly at start of therapy, and during dose adjustment. Monitor magnesium, alkaline phosphatase, parathyroid hormone levels (PTH) periodically; if PTH levels fall <1.5–3xULN, reduce calcitriol dose or discontinue. Pregnancy (Cat.C). Nursing mothers: not recommended.

Calcitriol Injection Pharmacokinetics

See Literature

Calcitriol Injection Interactions

Interactions

Hypermagnesemia with magnesium-containing antacids. Arrhythmias with digitalis if hypercalcemia occurs.

Calcitriol Injection Adverse Reactions

Adverse Reactions

Symptoms of hypervitaminosis D, hypercalcemia, hypercalciuria, hyperphosphatemia.

Calcitriol Injection Clinical Trials

See Literature

Calcitriol Injection Note

Notes

Formerly known under the brand name Calcijex.

Calcitriol Injection Patient Counseling

See Literature